Medifast Inc Stock Performance
| MED Stock | USD 19.44 1.12 6.11% |
MEDIFAST INC has a performance score of 4 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.14, which conveys not very significant fluctuations relative to the market. As returns on the market increase, MEDIFAST INC's returns are expected to increase less than the market. However, during the bear market, the loss of holding MEDIFAST INC is expected to be smaller as well. MEDIFAST INC at this time secures a risk of 2.73%. Please verify MEDIFAST INC maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to decide if MEDIFAST INC will be following its current price movements.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in MEDIFAST INC are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting technical and fundamental indicators, MEDIFAST INC may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
Actual Historical Performance (%)
One Day Return 6.11 | Five Day Return 5.54 | Year To Date Return (72.32) | Ten Year Return (34.37) | All Time Return 253.45 |
Dividend Date 2023-11-07 | Ex Dividend Date 2023-09-18 |
1 | Cognition Corporation Launches Compass MED A Revolutionary Solution to Simplify and Accelerate Medical Device Development | 09/10/2024 |
2 | The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Medifast, Inc. For Possible Securities Fraud | 09/25/2024 |
3 | Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024 | 10/21/2024 |
4 | Medifast Gears Up for Q3 Earnings Heres What You Should Know | 11/01/2024 |
5 | Medifast Posts Better-Than-Expected Sales In Q3 But Quarterly Guidance Underwhelms | 11/04/2024 |
6 | Earnings call Medifast reports Q3 decline, plans strategic pivot | 11/05/2024 |
7 | Are Investors Undervaluing MEDIFAST Right Now | 11/07/2024 |
8 | Acquisition by Jeffrey Brown of tradable shares of MEDIFAST INC at 106.93 subject to Rule 16b-3 | 11/13/2024 |
9 | How Should You Play Medifast Stock at a PE Multiple of 17.6X | 11/19/2024 |
10 | Plant-based Beverage Market is Estimated to Reach 56.73 Billion with a 11.9 percent CAGR By 2034 Fact.MR Reports | 11/20/2024 |
| Begin Period Cash Flow | 87.7 M |
MEDIFAST |
MEDIFAST INC Relative Risk vs. Return Landscape
If you would invest 1,794 in MEDIFAST INC on August 31, 2024 and sell it today you would earn a total of 150.00 from holding MEDIFAST INC or generate 8.36% return on investment over 90 days. MEDIFAST INC is generating 0.1639% of daily returns assuming volatility of 2.7279% on return distribution over 90 days investment horizon. In other words, 24% of stocks are less volatile than MEDIFAST, and above 97% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
MEDIFAST INC Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MEDIFAST INC's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MEDIFAST INC, and traders can use it to determine the average amount a MEDIFAST INC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0601
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MED | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.73 actual daily | 24 76% of assets are more volatile |
Expected Return
| 0.16 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average MEDIFAST INC is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MEDIFAST INC by adding it to a well-diversified portfolio.
MEDIFAST INC Fundamentals Growth
MEDIFAST Stock prices reflect investors' perceptions of the future prospects and financial health of MEDIFAST INC, and MEDIFAST INC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MEDIFAST Stock performance.
| Return On Equity | 0.0366 | ||||
| Return On Asset | 0.0477 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 60.3 M | ||||
| Shares Outstanding | 10.94 M | ||||
| Price To Earning | 13.99 X | ||||
| Price To Book | 1.03 X | ||||
| Price To Sales | 0.32 X | ||||
| Revenue | 1.07 B | ||||
| Gross Profit | 1.14 B | ||||
| EBITDA | 139.51 M | ||||
| Net Income | 99.42 M | ||||
| Cash And Equivalents | 87.69 M | ||||
| Cash Per Share | 5.57 X | ||||
| Total Debt | 22.01 M | ||||
| Debt To Equity | 0.43 % | ||||
| Current Ratio | 1.29 X | ||||
| Book Value Per Share | 19.47 X | ||||
| Cash Flow From Operations | 147.66 M | ||||
| Earnings Per Share | 0.67 X | ||||
| Market Capitalization | 212.63 M | ||||
| Total Asset | 309.91 M | ||||
| Retained Earnings | 174.65 M | ||||
| Working Capital | 131.73 M | ||||
| Current Asset | 88.07 M | ||||
| Current Liabilities | 23.56 M | ||||
About MEDIFAST INC Performance
By analyzing MEDIFAST INC's fundamental ratios, stakeholders can gain valuable insights into MEDIFAST INC's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MEDIFAST INC has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MEDIFAST INC has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 67.27 | 63.91 | |
| Return On Tangible Assets | 0.32 | 0.34 | |
| Return On Capital Employed | 0.58 | 0.61 | |
| Return On Assets | 0.32 | 0.34 | |
| Return On Equity | 0.49 | 0.84 |
Things to note about MEDIFAST INC performance evaluation
Checking the ongoing alerts about MEDIFAST INC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MEDIFAST INC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MEDIFAST INC is unlikely to experience financial distress in the next 2 years | |
| Over 86.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Plant-based Beverage Market is Estimated to Reach 56.73 Billion with a 11.9 percent CAGR By 2034 Fact.MR Reports |
- Analyzing MEDIFAST INC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MEDIFAST INC's stock is overvalued or undervalued compared to its peers.
- Examining MEDIFAST INC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MEDIFAST INC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MEDIFAST INC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MEDIFAST INC's stock. These opinions can provide insight into MEDIFAST INC's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for MEDIFAST Stock analysis
When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |